Please assess the completion status of the following clinical trial:

Trial Title: Azithromycin for Preterm Pre-labor Rupture of Membranes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Gestational age is between 28 wks and 37wks~2. Singleton living pregnancy.~3. Confirmed Premature Pre-labor rupture of membranes (PPROM).~Exclusion Criteria:~1. previable rupture of membranes (\<23+6wks)~2. Multiple gestations~3. Macrolide allergy~4. patient receiving combination macrolide therapy~5. lethal fetal anomalies~6. contraindications to expectant management of PPROM at time of diagnosis e.g. concurrent preterm labor, placental abruption, chorioamnionitis or non-reassuring fetal testing

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Azithromycin 1 day group (Type: OTHER): Patients will receive Azithromycin 1000mg once orally
- Azithromycin 5 days group (Type: OTHER): Patients will receive Azithromycin 500mg once orally, followed by Azithromycin 250mg orally daily for 4 days

Based on this trial design, predict the completion outcome and termination type (if applicable).